Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity ...

Major breakthrough in cancer treatment has been achieved by harnessing the capabilities of the immune system to both identify and eliminate cancer, even metastasized cancer. Mutations in cancer ...

Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck ...

Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity ...

The Office of Cancer Clinical Proteomics Research announced today its multi-institutional program to further the convergence of proteomics with genomics, or “proteogenomics,” to better understand the ...

Using an approach that includes integrating proteomics, genomics, and epigenomics data from 10 cancer types, researchers at the Baylor College of Medicine and collaborating institutions have ...

Proteogenomics and their applications in target cancer therapy research. The application of proteogenomics (mainly including genomics, transcriptomics, and proteomics) has become an indispensable tool ...

Proteogenomics explores how genetic information translates into protein expression and function, and the role of changes across DNA, RNA, and proteins in influencing disease development and ...

Doctors have nearly a dozen new targeted drugs to treat patients with acute myeloid leukemia, or AML, yet three of four patients still die within five years. Some patients succumb within just a month ...

Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity ...